US 8741863
Compound and method for treating myotonic dystrophy
granted A61KA61K31/7088A61K47/64
Quick answer
US patent 8741863 (Compound and method for treating myotonic dystrophy) held by Sarepta Therapeutics, Inc. expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/7088, A61K47/64, A61P, A61P21/00